General population screening for childhood type 1 diabetes: is it time for a UK strategy?. Issue 9 (5th November 2021)

• Record Type: Journal Article
• Authors: Besser, Rachel Elizabeth Jane; Ng, Sze May; Gregory, John W; Dayan, Colin M; Randell, Tabitha; Barrett, Timothy
• Is Part Of: Archives of disease in childhood. Volume 107:Issue 9(2022)
• Page Start: 790
• Page End: 795
• Publication Date: 2021-11-05
• Subjects: child health -- endocrinology -- global health; Children -- Diseases -- Periodicals; Infants -- Diseases -- Periodicals; 618.920005
• DOI: 10.1136/archdischild-2021-321864
• Languages: English
• ISSNs: 0003-9888

Abstract

Abstract : Type 1 diabetes (T1D) is a chronic autoimmune disease of childhood affecting 1:500 children aged under 15 years, with around 25% presenting with life-threatening diabetic ketoacidosis (DKA). While first-degree relatives have the highest risk of T1D, more than 85% of children who develop T1D do not have a family history. Despite public health awareness campaigns, DKA rates have not fallen over the last decade. T1D has a long prodrome, and it is now possible to identify children who go on to develop T1D with a high degree of certainty. The reasons for identifying children presymptomatically include prevention of DKA and related morbidities and mortality, reducing the need for hospitalisation, time to provide emotional support and education to ensure a smooth transition to insulin treatment, and opportunities for new treatments to prevent or delay progression. Research studies of population-based screening strategies include using islet autoantibodies alone or in combination with genetic risk factors, both of which can be measured from a capillary sample. If found during screening, the presence of two or more islet autoantibodies has a high positive predictive value for future T1D in childhood (under 18 years), offering an opportunity for DKA prevention. However, a single time-point test will not identify all children who go on to develop T1D, and so combining with genetic risk factors for T1D may be an alternative approach. Here we discuss the pros and cons of T1D screening in the UK, the different strategies available, the knowledge gaps and why a T1D screening strategy is needed.